Compare Kotak Mid Cap Fund vs Invesco India Mid Cap Fund
Kotak Mid Cap Fund
EquityMid Cap
Invesco India Mid Cap Fund
EquityMid Cap
Risk
Very High
Very High
Rating
4.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.51
1.87
NAV
₹150.91
₹215.67
Fund Started
12 Feb 2007
15 Feb 2007
Fund Size
₹66613.26 Cr
₹15748.83 Cr
Exit Load
Exit load for units in excess of 10% of the investment,1% will be charged for redemption within 365 days
Exit load for units in excess of 10% of the investment, 1% will be charged for redemption within 1 year.
1 Year
-7.06%
-5.11%
3 Year
12.72%
18.90%
5 Year
12.56%
14.95%
Equity
98.46%
98.74%
Cash
1.54%
1.26%
Top 10 Holdings
Name | Assets |
|---|---|
Ipca Laboratories Ltd. | 3.57% |
Fortis Healthcare Ltd. | 3.49% |
Vishal Mega Mart Ltd. | 3.04% |
L&T Finance Ltd. | 2.71% |
The Federal Bank Ltd. | 2.62% |
Mphasis Ltd. | 2.57% |
Kei Industries Ltd. | 2.45% |
GE Vernova T&D India Ltd | 2.45% |
Dixon Technologies (India) Ltd. | 2.44% |
Solar Industries India Ltd. | 2.41% |
Name | Assets |
|---|---|
Prestige Estates Projects Ltd. | 7.33% |
Max Healthcare Institute Ltd. | 7.21% |
Meesho Ltd. | 5.42% |
The Federal Bank Ltd. | 5.37% |
Manipal Health Enterprises Ltd. | 4.44% |
Eternal Ltd. | 4.14% |
Global Health Ltd. | 3.97% |
L&T Finance Ltd. | 3.91% |
AU Small Finance Bank Ltd. | 3.81% |
Indusind Bank Ltd. | 3.51% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long-term capital appreciation from a portfolio of equity and equity related securities, by investing predominantly in mid companies.
The scheme seeks to generate capital appreciation by investing predominantly in Mid cap entities.
Launch Date
12 Feb 2007
15 Feb 2007